Saint Bella GP disclosed that it repurchased 22,000 ordinary shares on 13 October 2026 through on-exchange transactions.
The repurchase was executed within a price range of HKD 2.81–2.84 per share, resulting in total consideration of HKD 0.06 million and a volume-weighted average cost of HKD 2.82 per share.
Post-transaction, issued shares outstanding (excluding treasury shares) declined to 615.29 million, representing a 0.0036% reduction in the free float. Treasury stock rose to 6.91 million shares, while total issued share capital (including treasury shares) remained unchanged at 622.20 million.
The purchases fall under the buyback mandate approved on 30 June 2026, which authorises repurchases of up to 62.22 million shares. Cumulative buybacks under this mandate now stand at 6.91 million shares, equivalent to 1.11% of the company’s issued share base at the mandate date.
A 30-day moratorium on new share issues or treasury-share disposals runs through 12 November 2026, in accordance with Hong Kong Stock Exchange rules.
Comments